Objective: High blood glucose levels have been associated with poor outcomes on prognosis in many diseases. This retrospective study evaluated the relationship between plasma glucose level and survival in patients diagnosed with Glioblastoma Multiforme [GBM].
Introduction
Glioblastoma is the most common malignant primary brain tumor in adults in the 5 th and 6 th decades. Most patients are treated with a combined approach, including adjuvant postoperative radiation therapy and adjuvant chemotherapy after surgery. Despite treatment, most patients have high recurrence rates and overall survival rates ranging from one to two years [1] [2] [3] [4] . Epidemiological studies have suggested that some types of cancer have a higher prevalence and mortality risk in patients with Diabetes Mellitus [DM] [5] . Hyperglycemia is defined as the condition of excess circulating glucose concentration. Hyperglycemia indirectly affects cancer cells with an increase in insulin/IGF-1 and cytokine levels in the body. In addition, there are studies in the literature suggesting that hyperglycemia has a direct effect on cancer cell proliferation, apoptosis and metastasis [5] [6] [7] . High glucose activates various signaling pathways by adversely affecting cancer cell behavior [8] .
The aim of this study was to investigate the relationship between glucose level and survival in patients with GBM. Note: The fasting mean plasma glucose levels for groups 1, 2, and 3 are <100, 100 to 126, >126 mg/dL, respectively
Patients and Methods
The data of 133 Glioblastoma Multiforme [GBM] patients who were followed in the oncology clinic between 2003 and 2016 were evaluated retrospectively. Demographic data, chemotherapy, radiotherapy, blood glucose levels, Karnofsky Performance Score levels. The first group FPG level was less than100 mg/dL, the second group FPG level was in the range of 100-126 mg/dL and the third group FPG level was greater than 126 mg/dL. Since KPS was not normally distributed for age and variances were not homogeneous, Kruskal Wallis was selected for statistical analysis.
The Chi-Square [RXC] test was performed for surgical option and gender evaluation in patients, and a table was created according to the Pearson P value. In order to assess the association between the investigated characteristics and overall survival status, multivariate
Cox proportional hazard regression analysis was utilized. SPPS 22 was used for statistical analysis. P <.05 was considered statistically significant ( Table 1) .
Results
The mean age of the patients was 53.9 ± 1.1 years. (Figure 1 ).
Figure 1:
Survival curves comparing groups of mean plasma fasting glucose level. The fasting mean plasma glucose levels for groups 1 to 3 are <100, 100 to 126, >126 mg/dL, respectively. Note: The fasting mean plasma glucose levels for groups one to three are <100, 100 to 126, >126 mg/dL, respectively. Abbreviations: HR, hazard ratio; KPS, Karnofsky performance score.
Discussion
The most important factors affecting prognosis in GBM patients are age and Karnofsky Performance Status [KPS]. In addition, the level of initial surgical resection is known to affect prognosis. In previously reported studies, the median overall survival of GBM patients is approximately 10 to 12 months [9] [10] [11] . In this study, no correlation was found between hyperglycemia and survival time in patients with GBM. Large population-based studies in the literature suggest that diabetes mellitus and impaired glucose tolerance are risk factors for the development of certain types of cancer [12, 13] .
It has been advocated that hyperglycemia frequently causes colon and breast cancers with high mortality and cancer recurrence [14] [15] [16] . Poor survival in colon and breast cancer in patients with diabetes, insulin proliferation has been emphasized to increase tumor [17] . High insulin levels have been shown to increase cancer cell proliferation [18, 19] . In addition, it has been observed that the incidence of breast adenocarcinomas is reduced in tumor-prone transgenic mice treated with metformin, which reduces insulin levels [20] . Rachel L. Derr et al. hyperglycemia was reported to be associated with short survival in 191 GBM patients [21] . In our study, not only KPS has a positive correlation with euglycemia but also it is an important factor for survival. We think that patients have low survival and the effects of hyperglycemia occur mostly in chronic period. Insulin has been shown to stimulate glucose uptake in cultures of human GBM cells [22] . While chronic effects of hyperglycemia can be demonstrated in in vivo studies, we suggest that this effect can be demonstrated more clearly in GBM patients only in long survival periods.
